Brainstorm Cell Therapeutics (BCLI) Insider Trading & Ownership $2.30 +0.41 (+21.69%) Closing price 04:00 PM EasternExtended Trading$2.38 +0.08 (+3.26%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Brainstorm Cell Therapeutics (NASDAQ:BCLI) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.70%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5,057.70Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$22,050.00 Get BCLI Insider Trade Alerts Want to know when executives and insiders are buying or selling Brainstorm Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BCLI Insider Buying and Selling by Quarter Brainstorm Cell Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/30/2024Chaim LebovitsCEOBuy1,466$3.45$5,057.70 7/19/2024Ibrahim B. DagherInsiderSell4,200$5.25$22,050.00 (Data available from 1/1/2013 forward) BCLI Insider Trading Activity - Frequently Asked Questions Who is on Brainstorm Cell Therapeutics's Insider Roster? The list of insiders at Brainstorm Cell Therapeutics includes Chaim Lebovits, Ibrahim B. Dagher, and Stacy Lindborg. Learn more on insiders at BCLI. What percentage of Brainstorm Cell Therapeutics stock is owned by insiders? 6.70% of Brainstorm Cell Therapeutics stock is owned by insiders. Learn more on BCLI's insider holdings. Which Brainstorm Cell Therapeutics insiders have been buying company stock? The following insiders have purchased BCLI shares in the last 24 months: Chaim Lebovits ($5,057.70), and Stacy Lindborg ($20,337.30). How much insider buying is happening at Brainstorm Cell Therapeutics? Insiders have purchased a total of 2,232 BCLI shares in the last 24 months for a total of $25,395.00 bought. Which Brainstorm Cell Therapeutics insiders have been selling company stock? The following insider sold BCLI shares in the last 24 months: Ibrahim B. Dagher ($22,050.00). How much insider selling is happening at Brainstorm Cell Therapeutics? Insiders have sold a total of 4,200 Brainstorm Cell Therapeutics shares in the last 24 months for a total of $22,050.00 sold. Brainstorm Cell Therapeutics Key ExecutivesMr. Chaim Lebovits (Age 53)President & Co-CEO Compensation: $878.78k1 recent tradesDr. Irit Arbel DSc (Age 64)Ph.D., Co-Founder & Independent Vice Chair of the Board Ms. Alla Patlis CPA (Age 37)M.B.A., Interim CFO & Controller Compensation: $130.92kMr. Uri Yablonka (Age 47)Executive VP, Chief Business Officer, Secretary & Director Compensation: $247.06kDr. Daniel Offen Ph.D.Chief Scientific AdvisorMs. Mary Kay TurnerSenior Vice President of Patient Advocacy & Government AffairsDr. Ibrahim Dagher M.D. (Age 55)Executive VP & Chief Medical Officer More Insider Trading Tools from MarketBeat Related Companies SCYX Insider Trading ITRM Insider Trading ELEV Insider Trading RAPT Insider Trading CALC Insider Trading ANEB Insider Trading CASI Insider Trading TPST Insider Trading CLNN Insider Trading QTTB Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:BCLI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Brainstorm Cell Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Brainstorm Cell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
